177 related articles for article (PubMed ID: 34338601)
1.
Jang SN; Park SY; Lee H; Jeong H; Jeon JH; Song IS; Kwon MJ; Liu KH
Xenobiotica; 2021 Oct; 51(10):1087-1094. PubMed ID: 34338601
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms.
Lee H; Heo JK; Lee GH; Park SY; Jang SN; Kim HJ; Kwon MJ; Song IS; Liu KH
Drug Metab Dispos; 2019 Dec; 47(12):1372-1379. PubMed ID: 31578207
[TBL] [Abstract][Full Text] [Related]
3. Identification of Human UDP-Glucuronosyltransferase 1A4 as the Major Isozyme Responsible for the Glucuronidation of 20(S)-Protopanaxadiol in Human Liver Microsomes.
Li J; He C; Fang L; Yang L; Wang Z
Int J Mol Sci; 2016 Mar; 17(3):205. PubMed ID: 27005621
[TBL] [Abstract][Full Text] [Related]
4. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
[TBL] [Abstract][Full Text] [Related]
5. Screening of non-steroidal anti-inflammatory drugs for inhibitory effects on the activities of six UDP-glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC-MS/MS.
Joo J; Kim YW; Wu Z; Shin JH; Lee B; Shon JC; Lee EY; Phuc NM; Liu KH
Biopharm Drug Dispos; 2015 May; 36(4):258-64. PubMed ID: 25522350
[TBL] [Abstract][Full Text] [Related]
6. Optimized methods for targeted peptide-based quantification of human uridine 5'-diphosphate-glucuronosyltransferases in biological specimens using liquid chromatography-tandem mass spectrometry.
Sato Y; Nagata M; Tetsuka K; Tamura K; Miyashita A; Kawamura A; Usui T
Drug Metab Dispos; 2014 May; 42(5):885-9. PubMed ID: 24595681
[TBL] [Abstract][Full Text] [Related]
7. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
8. Cabozantinib Carries the Risk of Drug-Drug Interactions
Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation.
Liu Y; Badée J; Takahashi RH; Schmidt S; Parrott N; Fowler S; Mackenzie PI; Coughtrie MWH; Collier AC
J Clin Pharmacol; 2020 Jun; 60(6):722-733. PubMed ID: 31879975
[TBL] [Abstract][Full Text] [Related]
11. Drug-Drug Interaction Potentials of Tyrosine Kinase Inhibitors via Inhibition of UDP-Glucuronosyltransferases.
Zhang N; Liu Y; Jeong H
Sci Rep; 2015 Dec; 5():17778. PubMed ID: 26642944
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases.
Xin H; Qi XY; Wu JJ; Wang XX; Li Y; Hong JY; He W; Xu W; Ge GB; Yang L
Food Chem Toxicol; 2016 Apr; 90():112-22. PubMed ID: 26875642
[TBL] [Abstract][Full Text] [Related]
13. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Sweated and Non-Sweated Ethanol Extracts of
Liu J; Shi Y; Wu C; Hong B; Peng D; Yu N; Wang G; Wang L; Chen W
Curr Drug Metab; 2022; 23(6):473-483. PubMed ID: 35585828
[TBL] [Abstract][Full Text] [Related]
15. Identification of human UDP-glucuronosyltransferase isoforms responsible for the glucuronidation of glycyrrhetinic acid.
Lu Y; Zhu J; Chen X; Li N; Fu F; He J; Wang G; Zhang L; Zheng Y; Qiu Z; Yu X; Han D; Wu L
Drug Metab Pharmacokinet; 2009; 24(6):523-8. PubMed ID: 20045987
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 5'-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes.
Heo JK; Nguyen PH; Kim WC; Phuc NM; Liu KH
Molecules; 2017 Sep; 22(10):. PubMed ID: 28934153
[No Abstract] [Full Text] [Related]
17. Human UDP-Glucuronosyltransferases 1A1, 1A3, 1A9, 2B4 and 2B7 are Inhibited by Diethylstilbestrol.
Zhu L; Xiao L; Li W; Zhang Y; Han W; Zhu Y; Ge G; Yang L
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):505-511. PubMed ID: 27176228
[TBL] [Abstract][Full Text] [Related]
18. Industrial Approach to Determine the Relative Contribution of Seven Major UGT Isoforms to Hepatic Glucuronidation.
Busse D; Leandersson S; Amberntsson S; Darnell M; Hilgendorf C
J Pharm Sci; 2020 Jul; 109(7):2309-2320. PubMed ID: 32294459
[TBL] [Abstract][Full Text] [Related]
19. Multiple circulating alkaloids and saponins from intravenous Kang-Ai injection inhibit human cytochrome P450 and UDP-glucuronosyltransferase isozymes: potential drug-drug interactions.
Qin Z; Jia M; Yang J; Xing H; Yin Z; Yao Z; Zhang X; Yao X
Chin Med; 2020; 15():69. PubMed ID: 32655683
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Inhibitory Effects of Synthetic Cannabinoid EAM-2201 on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kong TY; Kwon SS; Cheong JC; Kim HS; Kim JY; Lee HS
Molecules; 2018 Apr; 23(4):. PubMed ID: 29659506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
